Investor Overview

VYNE Therapeutics™ is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

0.26

Feb. 03, 2023 16:00:04
  • Change -0.0037 (-1.4286%)
  • Volume 242,152
  • Today's Open 0.27
  • Previous Close 0.259
  • Today's High 0.27
  • Today's Low 0.2541
  • 52 Week High 0.79
  • 52 Week Low 0.111